Biography

Yingzhong Li is the President of SunVax mRNA Therapeutics Inc. He holds 6 PCT patents at MIT and 3 PCT patents at SunVax in cancer immunology and mRNA techniques.

Before joining SunVax on October 30, 2021, Dr. Li gained extensive training and experience at MIT in Immunology, Synthetic Biology, Cancer Biology, and Cancer Immunotherapy.